COVID-19 Updates
From the Journals
Advanced Primary Care program boosts COVID-19 results
Better outcomes were seen in higher vaccination rates and fewer infections, hospitalizations, and deaths from COVID-19.
Latest News
What’s next for COVID? Here’s what to know
“We are in the midst of [a surge] now, It’s not nearly like what we’ve had in Omicron or other waves; it’s not as severe. But it’s being...
News from the FDA/CDC
Children and COVID: New cases fell as the old year ended
Emergency department visits keep increasing as the pandemic’s death toll in children nears 2,000.
Feature
Study of beliefs about what causes cancer sparks debate
The authors set out to evaluate “the patterns of beliefs about cancer among people who believed in conspiracies, rejected the COVID-19 vaccine, or...
From the Journals
Endocarditis tied to drug use on the rise, spiked during COVID
The steepest rise of infective endocarditis in people with cocaine/opioid use disorder occurred during the pandemic, suggesting COVID itself may...
News from the FDA/CDC
Children and COVID: New-case counts offer dueling narratives
Data from the American Academy of Pediatrics appear to conflict with information provided by the Centers for Disease Control and Prevention.
Feature
COVID booster shot poll: People ‘don’t think they need one’
A new poll shows why so few people are willing to get the latest COVID booster.
Feature
Multiple myeloma diagnosed more via emergency care during COVID
While trying to avoid COVID-19 infection, patients ultimately diagnosed with multiple myeloma may have delayed interactions with healthcare...
Feature
Rise of ‘alarming’ subvariants of COVID ‘worrisome’ for winter
This means people have no or “markedly reduced” protection against infection from these four strains.
Feature
U.S. sees most flu hospitalizations in a decade
But the number of deaths and outpatient visits for flu or flu-like illnesses was down slightly from the week before.
Feature
As COVID treatments dwindle, are new ones waiting in the wings?
Bebtelovimab couldn’t neutralize the Omicron subvariants BQ.1 and BQ.1.1.